Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
What is an Experiment?01:12

What is an Experiment?

An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

E-CIGARETTES: In the News.

Texas dental journal·2016
Same author

SPIT TOBACCO: A Changing Landscape.

Texas dental journal·2015
Same author

Knowledge Assessment of the Dental Community in Texas on the Role of Human Papilloma Virus in Oropharyngeal Cancer.

Texas dental journal·2015
Same author

Routine oral cancer screenings by primary care providers.

Texas dental journal·2014
Same author

Oral cancer: FAQ.

The Journal of the Michigan Dental Association·2014
Same author

Oral health care in cancer patients: you can make a difference!

Texas dental journal·2013
Same journal

TRENDING CULTURAL DRIVERS OF SMOKELESS TOBACCO: FOR RECENT REFUGEE AND IMMIGRANTS AS KNOWLEDGE, ATTITUDES, AND BEHAVIOR DETERMINANTS: A SOUTH TEXAS ORAL HEALTH NETWORK COLLABORATIVE STUDY.

Texas dental journal·2024
Same journal

Implementation of a youth and young adult e-cigarette cessation program within a dental clinic setting : A SToHN feasibility study.

Texas dental journal·2023
Same journal

Development of a Mobile Application to Enhance Knowledge, Awareness and Communication of Dry Mouth Amongst Dental Practitioners and Patients: A South Texas Oral Health Network Study.

Texas dental journal·2021
Same journal

Tooth Fairy Study- The South Texas Oral Health Network Collaboration.

Texas dental journal·2021
Same journal

HIPAA Compliance Doesn't Have to be Complicated 5 HIPAA Technical Safeguards Explained.

Texas dental journal·2019
Same journal

Energy output and in vitro biologic effects of an ionic toothbrush.

Texas dental journal·2019
See all related articles

Related Experiment Video

Updated: May 9, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

E-cigarettes: What's known, what's unknown.

K Vendrell Rankin1

  • 1Department of Public Health Sciences, The Texas A&M University Health Science Center, Baylor College of Dentistry, Dallas, TX 75246, USA. krankin@bcd.tamhsc.edu

Texas Dental Journal
|August 8, 2013
PubMed
Summary
This summary is machine-generated.

Electronic Nicotine Delivery Devices (e-cigarettes) use has surged. Their safety, efficacy for smoking cessation, and regulation remain debated topics for clinicians and researchers.

More Related Videos

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

Related Experiment Videos

Last Updated: May 9, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

Area of Science:

  • Public Health
  • Tobacco Control
  • Clinical Medicine

Background:

  • Electronic Nicotine Delivery Devices (e-cigarettes) have seen a significant rise in use and awareness since their 2007 U.S. market introduction.
  • Regulatory oversight by the Food and Drug Administration is limited, classifying them as tobacco products due to the absence of claimed therapeutic effects.

Purpose of the Study:

  • To address the ongoing scientific debate regarding the use, safety, chemical composition, and efficacy of e-cigarettes for smoking cessation.
  • To provide insights for clinicians managing patients who use e-cigarettes as a smoking replacement or cessation aid.

Main Methods:

  • Literature review and analysis of existing scientific studies on e-cigarette use and effects.
  • Examination of regulatory frameworks and classifications pertaining to e-cigarettes.
  • Synthesis of current evidence on safety, chemical constituents, and cessation efficacy.

Main Results:

  • Widespread adoption of e-cigarettes for various smoking behaviors, including reduction and cessation.
  • Significant scientific debate exists concerning the safety profile and long-term health implications of e-cigarette use.
  • Efficacy data for smoking cessation remains inconclusive and is a subject of ongoing research.

Conclusions:

  • The increasing prevalence of e-cigarettes presents complex challenges for public health and clinical practice.
  • Further research is crucial to establish definitive conclusions on the safety and efficacy of e-cigarettes for smoking cessation.
  • Clearer regulatory guidelines and evidence-based recommendations are needed to navigate the evolving landscape of e-cigarette use.